SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 12, 16:00
2846.45
-40.55 (-1.4%)
VOLUME 58,310
LIVE
NSE
Feb 12, 15:59
2847.45
-37.9 (-1.31%)
VOLUME 508,339
Announcements on Dr Reddys Labs

11th-Feb-2016 08:36Source: BSE

Dr Reddys Labs- Board to consider Buyback of Equity Shares

Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 17, 2016, inter alia, to consider the Buyback of Equity Shares of the Compa...

10th-Feb-2016 19:52Source: BSE

Dr Reddys Labs- Form 6K for the quarter and nine months ended December 31, 2015

Dr Reddys Laboratories Ltd has informed BSE regarding "Form 6K for the quarter and nine months ended December 31, 2015".

9th-Feb-2016 13:29Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated February 09, 2016, titled " Dr.Reddy''s Q3 and 9M FY16 Financial Results".

9th-Feb-2016 13:29Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.

8th-Feb-2016 09:16Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated February 08, 2016 titled "Promius Pharma Receives FDA Approval for Sernivo (betamethasone dipropionate) Spra...

8th-Feb-2016 09:13Source: BSE

Dr Reddys Labs- Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated February 08, 2016 titled "Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%".

1st-Feb-2016 12:45Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated February 01, 2016, titled "Dr. Reddy''s Laboratories Receives USFDA Tentative Approval for ZenavodTM (doxycy...

1st-Feb-2016 12:36Source: BSE

Dr Reddys Labs- Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated February 01, 2016 titled "Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules, 40...

29th-Jan-2016 13:53Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated January 29, 2016 titled "Dr. Reddy''s Laboratories Ltd. receives FDA approval for ZEMBRACETMSymTouchTM (suma...

29th-Jan-2016 13:53Source: BSE

Dr Reddys Labs- Dr. Reddy’s Laboratories Ltd. Receives FDA approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the acute treatment of migraines in adults

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 29, 2016 titled "Dr. Reddy’s Laboratories Ltd. Receives FDA approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) ...

1 2 3 4 5 Next >>
Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2016-02-17

Buy Back of Shares

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.